Brain Imaging Study Seeks to Understand Antipsychotic Effects of CBD

February 12, 2020 09:00:06

The past couple of years have brought a number of advancements for the health and wellness communities. From improving technologies to more potent and effective ingredients, there’s been a lot to be thankful for. And cannabidiol (CBD), a chemical produced by the cannabis plant, definitely tops the list of new and emerging opportunities.

The sale of CBD was only just legalized by the 2018 Farm Bill, and a year after the bill was passed, the CBD industry is already worth millions, with experts estimating it will hit $20 billion by 2026. According to users, CBD is a potent medicinal compound, and although there’s barely any research…

Read More >>

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.